PTX3
Pentraxin-related protein PTX3
Also known as: PTX3_HUMAN, TNFAIP5, TSG-14
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P26022
- Gene
- PTX3
- Ensembl
- ENSG00000163661
- Chromosome
- 3
- Canonical length
- 381 aa
- Protein class
- Plasma proteins, Predicted secreted proteins
- Subcellular location
- Plasma membrane
- Secretome location
- Secreted to blood
- Quaternary structure
- Homooctamer
OverviewNCBI Gene
This gene encodes a member of the pentraxin protein family. The expression of this protein is induced by inflammatory cytokines in response to inflammatory stimuli in several mesenchymal and epithelial cell types, particularly endothelial cells and mononuclear phagocytes. The protein promotes fibrocyte differentiation and is involved in regulating inflammation and complement activation. It also plays a role in angiogenesis and tissue remodeling. The protein serves as a biomarker for several inflammatory conditions. [provided by RefSeq, Jun 2016]
Canonical amino-acid sequenceUniProt
381 residues, UniProt reviewed canonical sequence.
>P26022|PTX3
1 MHLLAILFCA LWSAVLAENS DDYDLMYVNL DNEIDNGLHP TEDPTPCACG QEHSEWDKLF
61 IMLENSQMRE RMLLQATDDV LRGELQRLRE ELGRLAESLA RPCAPGAPAE ARLTSALDEL
121 LQATRDAGRR LARMEGAEAQ RPEEAGRALA AVLEELRQTR ADLHAVQGWA ARSWLPAGCE
181 TAILFPMRSK KIFGSVHPVR PMRLESFSAC IWVKATDVLN KTILFSYGTK RNPYEIQLYL
241 SYQSIVFVVG GEENKLVAEA MVSLGRWTHL CGTWNSEEGL TSLWVNGELA ATTVEMATGH
301 IVPEGGILQI GQEKNGCCVG GGFDETLAFS GRLTGFNIWD SVLSNEEIRE TGGAESCHIR
361 GNIVGWGVTE IQPHGGAQYV SLocalizationUniProt · AlphaFold · HPA
Whether an antibody against PTX3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 230 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 230 nTPM
- urinary bladder: 178 nTPM
- lung: 92 nTPM
- bone marrow: 84 nTPM
- breast: 56 nTPM
- heart muscle: 48 nTPM
Single-cell type
- neutrophil progenitors: 185 nCPM
- monocytes: 134 nCPM
- fibroblasts: 92 nCPM
- fallopian secretory cells: 90 nCPM
- neutrophils: 79 nCPM
- lymphatic endothelial cells: 75 nCPM
Immune cell
- eosinophil: 0.9 nTPM
- classical monocyte: 0.3 nTPM
- intermediate monocyte: 0.3 nTPM
- myeloid DC: 0.3 nTPM
- non-classical monocyte: 0.1 nTPM
- basophil: 0 nTPM
Brain region
- thalamus: 9.1 nTPM
- cerebral cortex: 3.8 nTPM
- choroid plexus: 2.2 nTPM
- hippocampal formation: 1.2 nTPM
- pons: 1.2 nTPM
- cerebellum: 1.1 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about PTX3.
Disease | ImmuneIEDB
Conditions an epitope on PTX3 was assayed in.
- systemic lupus erythematosus B cell
Disease | AutoantibodyPubMed
Conditions in which antibodies against PTX3 are reported. Each links to that disease's full target list.
ReferencesPubMed · IEDB
Publications for PTX3 from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
14 publications
- Anti-pentraxin 3 antibodies and residual disease activity in rheumatoid arthritis.
2025 · Rheumatology (Oxford) · RCR 2.3 · 6 citations - Detection of Anti-Pentraxin-3 Autoantibodies in ANCA-Associated Vasculitis.
2016 · PLoS One · RCR 1.4 · 32 citations - IgG anti-pentraxin 3 antibodies in systemic lupus erythematosus.
2010 · Ann Rheum Dis · RCR 1.3 · 48 citations - PTX3, Anti-PTX3, and Anti-C1q Autoantibodies in Lupus Glomerulonephritis.
2015 · Clin Rev Allergy Immunol · RCR 1.3 · 33 citations - Immunization with pentraxin 3 (PTX3) leads to anti-PTX3 antibody production and delayed lupus-like nephritis in NZB/NZW F1 mice.
2016 · J Autoimmun · RCR 1.2 · 28 citations
Show 9 more
- IgG anti-Pentraxin 3 antibodies are a novel biomarker of ANCA-associated vasculitis and better identify patients with eosinophilic granulomatosis with polyangiitis.
2021 · J Autoimmun · RCR 1.2 · 15 citations - Immunization with Pentraxin3 prevents transition from subclinical to clinical lupus nephritis in lupus-prone mice: Insights from renal ultrastructural findings.
2020 · J Autoimmun · RCR 0.7 · 12 citations - Successful treatment of anti-PTX3 positive seronegative rheumatoid arthritis with upadacitinib.
2024 · Int J Rheum Dis · RCR 0.6 · 2 citations - Detection of anti-PTX3 autoantibodies in systemic lupus erythematosus.
2009 · Rheumatology (Oxford) · RCR 0.6 · 23 citations - Anti-pentraxin 3 auto-antibodies might be protective in lupus nephritis: a large cohort study.
2017 · Ren Fail · RCR 0.6 · 13 citations - Circulating Pentraxin3-Specific B Cells Are Decreased in Lupus Nephritis.
2019 · Front Immunol · RCR 0.3 · 9 citations - Anti-pentraxin antibodies in autoimmune systemic diseases: Focus on anti-pentraxin-3 autoantibodies.
2017 · Int Rev Immunol · RCR 0.3 · 6 citations - Vaccination of mice for research purpose: alum is as effective as and safer than complete Freund adjuvant.
2012 · Reumatismo · RCR 0.3 · 7 citations - Autoantibodies against pentraxin-3 in systemic lupus erythematosus: mapping of reactivity to linear epitopes and associations with disease variables.
2025 · Autoimmunity · 1 citations
Reference: B cellIEDB
1 publication
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.2
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.05
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- extracellular matrix organization
- host-mediated suppression of symbiont invasion
- host-mediated suppression of viral proces
- inflammatory response
- innate immune response
- negative regulation by host of viral glycoprotein metabolic process
- negative regulation of glycoprotein metabolic process
- opsonization
- ovarian cumulus expansion
- positive regulation of nitric oxide biosynthetic process
- positive regulation of phagocytosis
- response to yeast
Molecular functions
- (1->3)-beta-D-glucan binding
- complement component C1q complex binding
- identical protein binding
- virion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Pentraxin domain
- LamG-like jellyroll fold
- Concanavalin A-like lectin/glucanase domain superfamily
- Pentaxin, conserved site
- Pentaxin family
- Pentraxin-related protein PTX3
- PTX3-like, N-terminal domain
- PTX3-like, N-terminal domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of PTX3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads PTX3 as an antibody target. Whether an autoantibody or antibody against PTX3 could matter depends on whether native PTX3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
PTX3 is annotated as secreted, so native PTX3 circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label PTX3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...